D. Boral Capital Begins Coverage on Estrella Immunopharma (NASDAQ:ESLA)
D. Boral Capital started coverage on shares of Estrella Immunopharma (NASDAQ:ESLA – Free Report) in a report published on Tuesday,Benzinga reports. The firm issued a buy rating and a $16.00 price target on the stock. Estrella Immunopharma Trading Up 13.8 % Shares of NASDAQ ESLA opened at $1.41 on Tuesday. Estrella Immunopharma has a 12 […]
